Michael J Reardon
Overview
Explore the profile of Michael J Reardon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
483
Citations
6928
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khalique O, Zaid S, Tang G, Abdel-Wahab M, Akodad M, Bapat V, et al.
J Am Coll Cardiol
. 2025 Mar;
85(10):1042-1055.
PMID: 40074470
This updated Heart Valve Collaboratory framework addresses the growing concern for transcatheter valve failure (TVF) following transcatheter aortic valve replacement (TAVR). With the increasing volume of redo-TAV and surgical TAV...
2.
Puri R, Spencer J, Tchetche D, Van Mieghem N, Forrest J, Reardon M, et al.
J Soc Cardiovasc Angiogr Interv
. 2025 Mar;
4(1):102448.
PMID: 40061419
Background: The native aortic annulus for self-expanding transcatheter aortic valve replacement (TAVR) has variable ellipticity. A noncircular and underexpanded transcatheter aortic valve (TAV) may impact hemodynamic performance. This study aimed...
3.
Reddy R, Howard J, Mack M, Reardon M, Jorgensen T, Horsted Thyregod H, et al.
J Am Coll Cardiol
. 2025 Mar;
85(9):926-940.
PMID: 40044297
Background: Longer-term outcomes are especially important for lower-risk patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR). Additional randomized data comparing TAVR...
4.
Qamar F, Kharsa C, Letham P, Aoun J, Goel S, Kleiman N, et al.
JACC Case Rep
. 2025 Feb;
30(4):102956.
PMID: 39972709
Around 2% of resected cardiac masses are ascribed to primary cardiac hemangiomas. With a variety of symptoms and variable natural history, these masses can be challenging to diagnose. This paper...
5.
Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening
Sato Y, Torii S, Kawai K, Yahagi K, Kutyna M, Kawakami R, et al.
Circ Cardiovasc Interv
. 2025 Feb;
18(2):e014523.
PMID: 39965045
Background: Hypoattenuated leaflet thickening (HALT) is believed to reflect leaflet thrombosis; however, no systematic histological examination of HALT has ever been performed. The aim of this study was to evaluate...
6.
Sammour Y, Anwaar M, Cabral-Amador F, Garcia J, Aoun J, Kazmi S, et al.
Heart Int
. 2025 Jan;
18(2):24-36.
PMID: 39885934
Tricuspid regurgitation (TR) is a common valvular heart disease that is associated with increased morbidity and mortality. Traditional surgical interventions, though definitive, carry considerable complexities and risks, especially for high-risk...
7.
Gupta T, Malaisrie S, Batchelor W, Boudoulas K, Davidson L, Ibebuogu U, et al.
J Thorac Cardiovasc Surg
. 2025 Jan;
PMID: 39798895
No abstract available.
8.
Al Abri Q, El Nihum L, Ali A, Nguyen D, Graviss E, MacGillivray T, et al.
Ann Thorac Surg Short Rep
. 2025 Jan;
1(1):164-167.
PMID: 39790534
Background: Complex or malignant left-sided heart tumors present a challenge for resection and reconstruction. Cardiac autotransplantation was developed to address this but is a complex technique. Partial autotransplantation was developed...
9.
Dang V, Haddad P, McFall R, Klopfenstein J, Reardon M, Rahimi M
J Vasc Surg Cases Innov Tech
. 2024 Dec;
11(1):101653.
PMID: 39649734
An 86-year-old male with multiple medical comorbidities was referred for an elective transcatheter aortic valve replacement (TAVR) for severe symptomatic aortic stenosis with an ejection fraction of 35%. A self-expanding...
10.
Takahashi K, Otsuki H, Zimmermann F, Ding V, Oldroyd K, Wendler O, et al.
JACC Cardiovasc Interv
. 2024 Dec;
18(2):157-167.
PMID: 39641725
Background: Outcomes in women after fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) using current-generation drug-eluting stents (DES) compared with coronary artery bypass grafting (CABG) are unknown. Objectives: This study...